| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/2007 | EP1750513A2 Use of gpcr54 ligands for the treatment of infertility |
| 02/14/2007 | EP1750506A2 Bi-lateral local renal delivery for treating congestive heart failure and for bnp therapy |
| 02/14/2007 | EP1750500A2 Ngal for reduction and amelioration of ischemic and nephrotoxic injuries |
| 02/14/2007 | EP1581253A4 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
| 02/14/2007 | EP1506234B1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 02/14/2007 | EP1442059B1 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 02/14/2007 | EP1423423B1 Methods for construction and screening of libraries of chemokine variants |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1392355B1 Use of proteasome inhibitors to treat dry eye disorders |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343523B1 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings |
| 02/14/2007 | EP1315750B1 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 02/14/2007 | EP1246639B1 Glp-2 formulations |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1169069B1 Use of three-dimensional stromal tissue for the treatment of ischemic tissue |
| 02/14/2007 | EP1143000B1 Screening method |
| 02/14/2007 | EP1140147B1 hCG THERAPY FOR THE TREATMENT OF METASTATIC BREAST CANCER |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1083929B1 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 02/14/2007 | EP1044983B1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 02/14/2007 | EP1035780B1 Method for purifying heat shock peptides complexes |
| 02/14/2007 | EP1034268B1 G-protein coupled receptors and uses therefor |
| 02/14/2007 | EP0871713B1 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 02/14/2007 | EP0833614B1 System and method for producing drug-loaded microparticles |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914335A Antisense oligonucleotide modulation of STAT3 expression |
| 02/14/2007 | CN1914168A Peptidyl arginine deiminase type IV inhibitor |
| 02/14/2007 | CN1913925A Compositions comprising two different populations of polymer-active agent conjugates |
| 02/14/2007 | CN1913924A Solid sustained-releasing formulation comprising triptorelin acetate |
| 02/14/2007 | CN1913917A Pharmaceutical composition for thrombin peptide derivatives |
| 02/14/2007 | CN1913916A Use of factor VIIA for treating trauma |
| 02/14/2007 | CN1913915A Methods for protecting against radiation using flagellin |
| 02/14/2007 | CN1913914A Pituitary adenylate cyclase activating peptide (PACP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 02/14/2007 | CN1913913A CAB molecules |
| 02/14/2007 | CN1913912A Pharmaceutical compositions and methods for insulin treatment |
| 02/14/2007 | CN1913911A Physiologically functional drinks and compositions |
| 02/14/2007 | CN1913888A Methods for reducing the effects of stress on skin condition |
| 02/14/2007 | CN1912141A Identification of genes |
| 02/14/2007 | CN1912115A Venomous snake thrombin sample enzyme modified by polyethylene glycol |
| 02/14/2007 | CN1912113A Protein and nuclein of antrodia camphoratu antioxidase and preparation method and use thereof |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1911958A Polypeptide for inhibiting p38 kinase activity and its application |
| 02/14/2007 | CN1911447A Transferrin-polyethylene glycol medicine molecular compound and its use |
| 02/14/2007 | CN1911442A Lysostaphin freeze dried powder used for preventing and treating trauma surface infestation |
| 02/14/2007 | CN1911441A Lysostaphin freeze dried powder used for preventing and treating cattle edometritis |
| 02/14/2007 | CN1911440A Kit used for forming fiber protein film and its application |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911437A Sobering-up beverage |
| 02/14/2007 | CN1911214A Method for preparing large quantity of micro-capsule |
| 02/14/2007 | CN1911102A Compounding agent for sobering and health-care, and its prodn, method |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300171C Preparation of myocardium peptide |
| 02/14/2007 | CN1300170C Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
| 02/14/2007 | CN1299767C Production of fowl leukocyte interferon |
| 02/14/2007 | CN1299766C Use of TGF-beta and growth factor in treatment and prevention of intestinal mucosa diseases |
| 02/14/2007 | CN1299765C Thymosin peptide oral tablet and its preparation method |
| 02/14/2007 | CN1299764C Preparing method of liposome endothelial chalone |
| 02/14/2007 | CN1299763C Method for preparing anti-hepatitis-B humanbody placenta transfer factor powder injecta |
| 02/14/2007 | CN1299690C Compositions for improving cardiovascular function |
| 02/14/2007 | CN1299688C Amino acid liquor and its preparation method |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176345 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
| 02/13/2007 | US7176302 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176292 Ghrelin variant protein |
| 02/13/2007 | US7176290 Tau protein epitopes for use in the treatment of alzheimer's disease |
| 02/13/2007 | US7176288 Human coagulation factor VII variants |
| 02/13/2007 | US7176286 Antigen fragments for the diagnosis of Toxoplasma gondii |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176282 Solid-phase peptide synthesis and agent for use in such synthesis |
| 02/13/2007 | US7176281 Phospholipase A2-inhibitory peptide with anti-arthritic and neuroprotective activities |
| 02/13/2007 | US7176280 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use |
| 02/13/2007 | US7176279 melanocortin receptor-specific; phosphodiesterase inhibitors; erectile dysfunction |
| 02/13/2007 | US7176278 Modified transferrin fusion proteins |
| 02/13/2007 | US7176277 Conversion of apoptotic proteins |
| 02/13/2007 | US7176276 Antimicrobial peptide and use thereof |
| 02/13/2007 | US7176275 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107, antibodies specific for the peptides and methods of stimulating immune response; antisense agents |
| 02/13/2007 | US7176261 A cylindrical stent having a controlled-release amphiphilic coating of polyoxyethylene glycol methacrylate/cyclohexyl methacrylate copolymer and angiotensin-(1-7) receptor agonist on the exterior or interior surface; inhibiting post-stent implantation complications; vascular systems; drug delivery |
| 02/13/2007 | US7176243 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis |
| 02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 02/13/2007 | US7176189 Methods for regeneration of a mammalian lens |
| 02/13/2007 | US7176188 Method of lethally sensitizing human and animal cells |
| 02/13/2007 | US7176184 Treatment for inflammatory bowel disease with a fibronectin polypeptide |
| 02/13/2007 | US7176183 Methods for treating and preventing damage to mucosal tissue |
| 02/13/2007 | US7176182 Methods of enhancing functioning of the large intestine |
| 02/13/2007 | US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176179 Polypeptide characterized by: a) a nuclear localization sequence, b) amino acid residues 75 108 of SEQ ID NO:2 retaining selective apoptosis-inducing activity, and c) an affinity ligand |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7176013 Serine protease variant for use in diagnosis, prevention and treatment of cardiovascular disorders |
| 02/13/2007 | US7176010 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes |
| 02/13/2007 | US7175999 Identifying nucleotide sequences which code fat metabolism regulator protein (lpo-4)s for preventing and treating obesity and eating disorders |